Aequitas vs Marcellus: A Head-to-Head PMS Comparison for 2026

A Portfolio Management Service (PMS) is a SEBI-regulated investment product where a licensed manager runs a discretionary, direct-equity portfolio on your behalf  but unlike a mutual fund, the shares sit in your own demat account, not in a pooled trust. This structure, closer to what global markets call a separately managed account, gives investors direct ownership, full portfolio transparency, and  crucially  the ability to pick a manager whose stated philosophy they actually believe in, rather than buying into a fund's generic mandate.

That last point is exactly why Aequitas and Marcellus get compared so often. Both are boutique, founder-led PMS houses with clearly articulated, almost opposite investment philosophies, and both have built large enough track records (13 years for Aequitas's flagship strategy, nearly 8 years for Marcellus's) that investors can actually judge them on results rather than pitch decks. When someone is deciding between "a concentrated small-cap bet" and "a quality large-cap compounding strategy," these two names are frequently the shorthand for that choice.

PMS as a regulated category exists in India because of the SEBI (Portfolio Managers) Regulations, which set out licensing, disclosure, and investor-protection rules  including the ₹50 lakh minimum investment floor that both Aequitas and Marcellus operate under today. The SEBI investor education portal is a good primer if you want the regulator's own plain-language explanation of how PMS differs from a mutual fund.

Over the last decade, this regulatory scaffolding gave rise to a wave of boutique, founder-led PMS houses distinct from the older bank- and brokerage-backed players  and the industry has grown fast enough to now manage well over ₹44 lakh crore across all providers as of mid-2026, according to Business Line's reporting on APMI data.

Aequitas Investment Consultancy was built around Siddhartha Bhaiya's concentrated, contrarian approach to small- and mid-cap Indian equities, launching its flagship India Opportunities Product in February 2013. Marcellus Investment Managers arrived later, in 2018, when Saurabh Mukherjea  who had built a following as CIO at Ambit Capital popularising "Coffee Can Investing"  co-founded the firm with Rakshit Ranjan and Pramod Gubbi around a very different idea: buy only businesses with a decade-long record of high, clean Return on Capital Employed, and change the portfolio as little as possible. Its flagship Consistent Compounders Portfolio launched in December 2018, followed by four more strategies (Kings of Capital, Little Champs, Rising Giants, and Meritor Q) between 2019 and 2022.

The two firms' philosophies are close to mirror images of each other.

Aequitas describes itself as a boutique asset manager "specialised in listed small-cap Indian equities," built around "identifying high-quality companies with strong business fundamentals, scalable growth potential, and attractive valuations, using a blend of growth and contrarian strategies." In practice: concentrated, high-conviction bets in under-covered small and mid-cap names, often taken against the market's current mood, on the expectation of a multi-year re-rating.

Marcellus runs on the opposite instinct: remove the need for a market-timing call entirely. Its two-stage filter looks for businesses with a decade-plus of double-digit revenue growth, a consistently high Return on Capital Employed (ROCE), clean accounting, durable pricing power, and disciplined capital allocation  then holds 10–20 of them with deliberately low portfolio churn. Marcellus is explicit that this approach will lag the market during "momentum-driven bull markets" led by lower-quality, cyclical names, because it is structurally excluding exactly those names by design.

In one sentence: Aequitas is underwriting stock-specific mispricing at the smaller end of the market; Marcellus is underwriting business quality, betting that governance and capital efficiency get rewarded over a full economic cycle  even at the cost of looking wrong for stretches of it.

Choosing between strategies like these used to mean requesting brochures from each AMC and comparing them by hand. That's changed. SEBI's digital KYC has made onboarding to a PMS largely paperless, and independent tracking platforms now publish near-real-time performance, AUM, and fee data across hundreds of strategies  the same kind of tracker data (PMS Bazaar, PMS AIF World, BusinessToday's PMS tracker) that underpins the performance numbers in this article.

The next layer is AI-assisted comparison: instead of manually cross-referencing disclosure documents from a dozen AMCs, tools can now screen an investor's existing portfolio for sector overlap, match a stated risk profile against a database of 1,000+ live strategies, and flag concentration risk before it becomes a problem. That shift  from "read the marketing deck" to "compare the actual numbers, live"  is precisely the gap independent, data-first PMS content and comparison platforms are built to close (more on this in the "How PMS Sahi Hai's Nyra Helps You Decide" section below).

This is where the two houses diverge most sharply  and where headline narratives matter less than the actual numbers.

Marcellus  All Five PMS Strategies

The gap is stark. Aequitas's flagship has delivered small-cap-scale returns across every trailing period shown. Marcellus's flagship, by contrast, has struggled: an independent review by Holistic Investment (March 2026) calculated that Consistent Compounders' 5-year annualised return of roughly 3.14% compares to the Nifty 50 TRI's ~10.01% over the same period  a shortfall of nearly 7 percentage points a year, with negative alpha across every measurable window back to inception.

Context matters here, though. This gap has opened up during a period when smaller, more cyclical names have been broadly rewarded: Business Standard reported that, as of late August 2026, the Nifty Smallcap 100 was outperforming the Nifty 50 by over 20 percentage points year-to-date, with the Nifty 50 itself down roughly 7.8% while smallcaps gained over 12%. That is almost exactly the environment Marcellus tells its own clients to expect underperformance in  its quality filter deliberately excludes the more cyclical, higher-beta names driving that smallcap rally. Whether that's a temporary cyclical mismatch or a deeper problem with the strategy is a judgment call every investor has to make for themselves; it isn't one the numbers alone can settle, but the numbers are the right place to start.

A performance fee is only charged on profits, and a hurdle rate means the manager doesn't earn that fee until returns clear a minimum bar first  Marcellus's variable plans build in an 8–12% hurdle; Aequitas's variable plan does not appear to state one, which is worth clarifying directly with the AMC, since it changes the fee math meaningfully in flat or modestly positive years. Both firms sit at the higher end of the fee spectrum that's typical for concentrated, actively managed PMS strategies in India  broadly in line with the category, not outliers in either direction.

Advantages:

• Direct ownership and transparency  the stocks sit in your own demat account, not a pooled trust, so you can see exactly what you hold at all times.
• Strategy specialization  you can deliberately choose a house style (Aequitas's small-cap contrarian bets, or Marcellus's large-cap quality compounding) to fill a specific gap in your existing portfolio.
• High-conviction, concentrated portfolios  typically 10–20 stocks, versus the much larger books many diversified mutual funds run.
• Named-manager accountability  performance and portfolio decisions are attributable to a specific person or team, not an anonymous, rotating fund-management bench.
• Fee-performance alignment  both firms offer variable-fee plans that link part of the cost directly to delivered returns rather than a flat AUM-based fee alone.

Disadvantages:

• High minimum ticket  the SEBI-mandated ₹50 lakh floor concentrates a meaningful chunk of an investor's net worth into one strategy, unlike a mutual fund SIP that can start with a few thousand rupees.
• Higher total cost  a 2% fixed fee, sometimes plus a 10–20% performance fee, is materially higher than a passive index fund, and can become a large cumulative drag if returns disappoint, as the Marcellus review above illustrates.
• Real underperformance and concentration risk  a concentrated, house-view-driven portfolio can lag its benchmark for years (Marcellus's Consistent Compounders) or run meaningfully more volatile than the broader market (typical of small-cap concentration like Aequitas's), and the investor bears that risk directly, with no diversification cushion from other managers' calls.

Even setting recent returns aside, these are structurally different risk profiles, and it's worth being honest about what each is actually built to do.

Aequitas's concentrated small-cap book will be more volatile, more sensitive to liquidity in a drawdown, and more dependent on continued small-cap re-rating and the fund managers' stock-picking edge holding up over time. The reward for that risk has shown up clearly in the last several years of numbers  the open question for any prospective investor is how much of that reward is repeatable skill versus a favourable multi-year small-cap cycle that eventually turns.

Marcellus's large-cap, high-ROCE book is designed to be the more defensive, lower-beta side of an equity portfolio  the part meant to protect capital in a downturn even at the cost of lagging in a raging small-cap-led bull market. Its recent numbers are the clearest live test yet of whether that defensiveness shows up when investors actually need it, or whether the "quality premium" itself has simply gone out of fashion for now.

Neither is inherently the "safer" or "better" choice in the abstract  they're built to do different jobs inside a portfolio, and your own time horizon, existing allocation, and tolerance for being wrong in the short run should drive the decision far more than either firm's own marketing narrative does.

• Growth-seeking investors with a higher risk tolerance, comfortable with concentration and volatility, and chasing small/mid-cap alpha, have gravitated toward Aequitas  and the recent numbers explain why.
• First-time PMS investors prioritising capital preservation and governance quality over short-term returns have typically gravitated toward Marcellus's positioning  though the last few years are a genuine, live test of that thesis that deserves an honest look rather than being taken on faith.
• Investors with an existing large-cap/quality-tilted core may look to an Aequitas-style strategy for small/mid-cap satellite diversification  and the reverse is true for investors overweight small-caps looking for a Marcellus-style ballast.
• Investors who aren't sure which camp they're in  and there's no shame in that, since these are two genuinely different bets  are usually better served checking how either strategy would sit alongside what they already hold before committing ₹50 lakh-plus to either one. That's a portfolio-fit question, not just a "who has better trailing returns" question.

Reading a comparison like this one is a good starting point  but Aequitas and Marcellus are only two names out of hundreds of SEBI-registered PMS and AIF strategies competing for the same ₹50-lakh-plus allocation. That's exactly the problem PMS Sahi Hai was built to solve. As India's AI-powered PMS & AIF marketplace, it lets investors compare, evaluate, and invest across the full landscape rather than researching each AMC's disclosure documents one at a time.

At the centre of that experience is Nyra, PMS Sahi Hai's AI Wealth Compass, available at nyra.pmssahihai.com. Nyra's five-step process  profile and goals, portfolio analysis, curated matching, smart investing, and continuous monitoring  is designed for exactly the decision this article walks through: instead of reading Aequitas's and Marcellus's return tables side by side and guessing at the fit, Nyra's PMS comparison tool evaluates over 1,000 tracked strategies against your specific risk appetite, time horizon, and existing holdings  including flagging hidden sector overlap if you already hold a strategy that clashes with either firm's concentrated bets. If you're weighing a concentrated small-cap contrarian strategy like Aequitas's against a large-cap quality compounder like Marcellus's, that portfolio-fit context is exactly what separates a good decision from a purely return-chasing one.